NCT02443532

Brief Summary

Patients with type 1 diabetes aged 15-65 years without major complications will be randomized either to usual care or to a structured group education program, with 6 four-hour weekly interactive sessions devoted to diabetes management. The principal endpoint will be the variation of HbA1c at 12 months from enrolment. Secondary endpoints will include quality of life, treatment satisfaction, fear of hypoglycemia, incidence of hypoglycemia.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2012

Longer than P75 for not_applicable

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2012

Completed
3.2 years until next milestone

First Submitted

Initial submission to the registry

May 4, 2015

Completed
10 days until next milestone

First Posted

Study publicly available on registry

May 14, 2015

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 8, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 8, 2018

Completed
Last Updated

June 4, 2018

Status Verified

June 1, 2018

Enrollment Period

5.9 years

First QC Date

May 4, 2015

Last Update Submit

June 1, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • HbA1c (between-group difference in variation from baseline)

    12 months

Secondary Outcomes (4)

  • Quality of life (Well-being enquiry in Diabetics [WED] questionnaire)

    12 months

  • Treatment satisfaction (Diabetes Treatment Satisfaction [DTS] questionnaire)

    12 months

  • Fear of hypoglycemia (Fear of Hypoglycemia [FH-15] questionnaire)

    12 months

  • Severe hypoglycemia (incidence of episodes of hypoglycemia requiring hospitalization and/or help from third parties, self-reported)

    12 months

Study Arms (2)

Structured Group education

EXPERIMENTAL

Six weekly interactive group sessions of 4 hours each, providing information and developing skills for diabetes self-management, including eating habits, food composition, calculation of bolus insulin, information on physical exercise, blood glucose self-monitoring, management of hypoglycemia.

Behavioral: Structured group education

Individual education

OTHER

Usual care (individual consultations as routinely performed)

Behavioral: Individual education

Interventions

The group intervention consists of interactive sessions for groups of 5-7 patients, dealing with different aspects of management of type 1 diabetes: insulin therapy and hypoglycemia, management of insulin doses, diet, physical exercise, sick days, etc. The intervention is designed for the acquisition of specific skills of self-management. This intervention is provided by a team including physicians, dietitians, and nurses.

Structured Group education

Usual care (individual consultations as routinely performed)

Individual education

Eligibility Criteria

Age15 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • type 1 diabetes

You may not qualify if:

  • serious diabetic complications, such as to interfere with physical functioning (e.g., lower limb amputation, renal failure requiring dialysis, blindness)
  • Illiteracy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Diabetology Unit

Study Record Dates

First Submitted

May 4, 2015

First Posted

May 14, 2015

Study Start

March 1, 2012

Primary Completion

January 8, 2018

Study Completion

January 8, 2018

Last Updated

June 4, 2018

Record last verified: 2018-06